Healthcare Business - Page 2

biotech word cloud

Why These 5 Biopharma Stocks Are Making Massive Gains on Thursday

As the markets are continuing to heat up a few biotech and pharma companies made massive gains on Thursday. There is a very positive sentiment in the health care sector ...
Read Full Story »
Prescription drugs

2017 Bull-Bear Case for Health Care: J&J, Merck, Pfizer, UnitedHealth

Major Dow Jones Industrial Average companies in the health care sector saw a relatively strong 2016, with most posting a solid gain on the year. One of these stocks was ...
Read Full Story »
Jon's friends

Wednesday’s Top 5 Biopharma Movers

Biotech and pharma companies were on the move Wednesday. A few made absolutely massive gains on the day, giving more credence to the Trump rally and positive sentiment for the health care ...
Read Full Story »
IPO

Braeburn Pharmaceuticals Gears Up for IPO

Braeburn Pharmaceuticals has registered an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were given in the filing, but ...
Read Full Story »
Prescription drugs

Tuesday’s Biggest Biotech and Pharma Moves

To kick off the New Year, a few biotech companies made massive runs on this first day of trading in 2017. The health care sector was in trouble over the ...
Read Full Story »
IPO

Jounce Therapeutics Files for IPO

Jounce Therapeutics has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were given in the filing, but ...
Read Full Story »
blue eye

Is This the Implosion of Inotek?

Inotek Pharmaceuticals Corp. (NASDAQ: ITEK) saw its shares get more than halved early on Tuesday after the company provided an update on its late-stage glaucoma trial. Unfortunately, the Phase 3 ...
Read Full Story »
Unhealthy Person

3 Sleeper Biotechs That Could Bounce Back Strong in 2017

When traders look at a stock at its highs and imagine what would be had they gotten in at the lows, the thought that invariably gets triggered is “At the ...
Read Full Story »
Female patient on gurney

Will 2017 Be a Make or Break Year for FibroGen?

FibroGen Inc. (NASDAQ: FGEN) could be a very important stock in the biotech and pharma industries within health care in 2017. While the 35% post-election rally in FibroGen shares is ...
Read Full Story »
FDA_logo

7 Key FDA Decisions and Catalysts Expected in January and February

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk to a ...
Read Full Story »
Good heart health

EndoLogix Recovers Slightly After Resuming Shipments

Endologix Inc. (NASDAQ: ELGX) reported earlier this week that it would be placing a temporary hold on the shipments of its abdominal aortic aneurysms (AAA) products. Shares dropped about 27% ...
Read Full Story »
tired frustrated unhappy business person

Cempra Shares Get Halved After Receipt of CRL From the FDA

Shares of Cempra Inc. (NASDAQ: CEMP) were halved on Thursday after the company received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA). The CRL was relating ...
Read Full Story »
FDA_logo

Galena Rises on FDA Approval

Galena Biopharma, Inc. (NASDAQ: GALE) saw its shares jump on Wednesday after a key U.S. Food and Drug Administration (FDA) approval. The company announced that it has confirmed the regulatory ...
Read Full Story »
Prescription drugs

Short Interest Rises in Major Pharma

The short interest data have been released for the December 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
biotech word cloud

Biotech Short Interest Sinks

The short interest data are out for the most recent settlement date, December 15. Generally speaking, companies within the biotech industry are considered to have a riskier group of stocks, ...
Read Full Story »